Bibliography

Export 7 results:

Filters: Author is Champlin,R. E. [Clear All Filters]

2008

Koca E, Champlin RE. Peripheral blood progenitor cell or bone marrow transplantation: controversy remains. Currrent Opinion in Oncology. 2008;20(2):220-226.

2006

Qazilbash MH, Ueno NT, Hosing C, de Lima M, Cortes J, Massaro A, et al. Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;38(5):393-394.

2003

Hong DS, Jacobson KL, II R, de Lima M, Anderlini P, Fuller GN, et al. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis. 2003;37(8):1044-9.

2002

Anderlini P, Chan FA, Champlin RE, Korbling M, Strom SS. Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: No evidence of increased risk of leukemia development. Bone Marrow Transplant. 2002;30:661-663.

2001

Anderlini P, Rizzo JD, Nugent ML, Schmitz N, Champlin RE, Horowitz MM. Peripheral blood stem cell donation: An analysis from the international bone marrow transplant registry (IBMTR) and eurpoean group for blood and marrow transplant (EBMT) databases. Bone Marrow Transplant. 2001;27:689-692.

1999

Anderlini P, Donato M, Chan KW, Huh YO, Gee AP, Lauppe MJ, et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion. 1999;39(6):555-60.

1992

Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood. 1992;79(11):3076-85.